Standard BioTools Inc. (LAB)

Standard BioTools Revenue

Standard BioTools had revenue of $21.15M in the quarter ending March 31, 2026, with 4.57% growth. This brings the company's revenue in the last twelve months to $86.26M, down -3.71% year-over-year. In the year 2025, Standard BioTools had annual revenue of $85.33M, down -6.24%.

• Revenue (ttm): $86.26M
• Revenue Growth: -3.71%
• P/S Ratio: 3.93
• Revenue / Employee: $221,735
• Employees: 389
• Market Cap: 348.64M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	85.33M	-5.68M	-6.24%
Dec 31, 2024	91.01M	-15.33M	-14.42%
Dec 31, 2023	106.34M	8.39M	8.57%
Dec 31, 2022	97.95M	-32.63M	-24.99%
Dec 31, 2021	130.58M	-7.56M	-5.47%
Dec 31, 2020	138.14M	20.90M	17.83%
Dec 31, 2019	117.24M	4.28M	3.79%
Dec 31, 2018	112.96M	11.03M	10.82%
Dec 31, 2017	101.94M	-2.51M	-2.40%
Dec 31, 2016	104.45M	-10.27M	-8.95%
Dec 31, 2015	114.71M	-1.74M	-1.50%
Dec 31, 2014	116.46M	45.27M	63.60%
Dec 31, 2013	71.18M	18.85M	36.02%
Dec 31, 2012	52.33M	9.47M	22.09%
Dec 31, 2011	42.87M	9.31M	27.73%
Dec 31, 2010	33.56M	8.15M	32.06%
Dec 31, 2009	25.41M	10.07M	65.58%
Dec 27, 2008	15.35M	8.07M	110.96%
Dec 29, 2007	7.28M	877.00K	13.71%
Dec 31, 2006	6.40M	-1.28M	-16.63%
Dec 31, 2005	7.67M	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error